Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Necrotic and denatured extracellular matrix and wound debris proteins represent the non-viable proteinaceous material that accumulates in chronic and acute wounds. This material, often referred to as eschar or slough, consists of denatured collagen, fibrin, and other cellular remnants that have lost their biological function due to ischemia, infection, or trauma (StatPearls, Wound Debridement, 2023). In the context of wound healing, these proteins act as a physical barrier to re-epithelialization and provide a niche for bacterial colonization and biofilm formation (Wound Repair and Regeneration, 2013). Therapeutic intervention focuses on enzymatic debridement, where exogenous proteases are applied to selectively digest these denatured proteins without harming healthy tissue. By removing this debris, the wound environment is optimized for granulation tissue formation and subsequent closure (Journal of Wound Care, 2019). Common agents targeting this substrate include collagenase and bromelain-based concentrates, which break down the structural integrity of the necrotic mass (FDA, Santyl Prescribing Information; EMA, NexoBrid Summary of Product Characteristics).
Enzymatic proteolysis and digestion of denatured extracellular matrix components and necrotic debris to facilitate wound bed preparation and promote healing.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Necrotic and denatured extracellular matrix and wound debris proteins.